CS

Christopher Stone

CEO, General Counsel & Secretary at PDL BioPharma

Christopher Stone, the CEO, General Counsel and Secretary, joined the Company in February 2009 as VP, General Counsel and Secretary and assumed the role of CEO on May 15, 2021. He brings more than 30 years of legal experience. Before joining PDL, Mr. Stone served as Vice President of Legal Affairs and Corporate Secretary at LS9, an advanced biofuels development company, where his work included a focus on intellectual property protection, research collaborations and licensing.

Prior to that, Mr. Stone was Vice President of Intellectual Assets USA at Danisco A/S, a global producer of food ingredients, enzymes and bio-based solutions. From 1994 to 2005, Mr. Stone was with Genencor International, a biotechnology company acquired by Danisco in 2005, most recently as Vice President of Intellectual Property and General Patent Counsel. At Genencor, he handled all intellectual property matters, including developing and implementing an overall strategy for its domestic and international patent estate of approximately 3,700 patents and patent applications and intellectual property transactions including licensing and research collaboration management, and managed multiple litigation and interference proceedings and numerous European patent oppositions.

Mr. Stone received a J.D. from the National Law Center at George Washington University and a B.S. in Biochemistry from the University of Massachusetts. He is an active member of the District of Columbia Bar, Nevada Bar and California Bar, and was admitted to practice before the United States Patent & Trademark Office in 1992.

Links

Org chart

Peers

Timeline

  • CEO, General Counsel & Secretary

    May, 2021 - present

  • Vice President and General Counsel

View in org chart